Continuous glucose sensor using novel genetically engineered binding polypeptides towards in vivo applications

Abstract As the importance of blood-glucose control for both diabetic and non-diabetic patients continues to increase, there is a need for more advanced glucose-sensing technologies. In particular, an in vivo glucose sensor is needed that exhibits high accuracy when operating in a continuous manner for a relatively long period of time (3–5 days). Development of such sensors has been hampered, as low accuracy and sensor drift become major problems with in vivo environments, especially for enzyme-based electrochemical glucose sensors. This paper reports on the use of a novel, binding polypeptide-based, fluorescent, glucose-sensing system that promises to overcome many drawbacks of an enzyme-based system while showing the potential for high accuracy, especially at hypoglycemic levels. Fluorescently labeled glucose recognition polypeptide elements were immobilized in a polyacrylamide hydrogel matrix placed on the tip of an optical fiber to realize a continuous glucose-sensing device towards in vivo applications. In vitro validation was performed in both buffered solutions and whole blood to characterize sensor parameters such as sensitivity and response time. Testing demonstrated that the reagentless polypeptide-based glucose-sensing system has extreme sensitivity in the hypoglycemic levels while providing high precision across the entire human physiologic glucose range. Additionally, the sensor was shown to function at physiologic temperature ( viz. , 37 °C) and displayed high selectivity for glucose without interference from other sugars ( viz. , fructose). This represents the first report of implementing immobilized glucose binding protein-like elements in a sensing device for continuous glucose monitoring, and establishes proof-of-concept as an excellent alternative to overcoming problems of current long-term, continuous glucose-sensing technologies.

[1]  J. Krinsley Glycemic Variability and Mortality in Critically 111 Patients: The Impact of Diabetes , 2009, Journal of diabetes science and technology.

[2]  G. Grunkemeier,et al.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.

[3]  S. Daunert,et al.  Phosphate binding protein as the biorecognition element in a biosensor for phosphate. , 2004, Sensors and actuators. B, Chemical.

[4]  Maryclare Prasnikar,et al.  Comparison of point-of-care and laboratory glucose analysis in critically ill patients. , 2007, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[5]  Alexander Schiller,et al.  A fluorescent sensor array for saccharides based on boronic Acid appended bipyridinium salts. , 2007, Angewandte Chemie.

[6]  S. d'Auria,et al.  Conformational stability and domain coupling in D-glucose/D-galactose-binding protein from Escherichia coli. , 2004, The Biochemical journal.

[7]  Miet Schetz,et al.  Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units , 2006, Diabetes.

[8]  C. Toumazou,et al.  Glucose sensors: a review of current and emerging technology , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[9]  G L Coté,et al.  A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. , 1999, Analytical chemistry.

[10]  G. Angelini,et al.  Inadequate Blood Glucose Control Is Associated With In-Hospital Mortality and Morbidity in Diabetic and Nondiabetic Patients Undergoing Cardiac Surgery , 2008, Circulation.

[11]  G. V. Berghe,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[12]  R J McNichols,et al.  Optical glucose sensing in biological fluids: an overview. , 2000, Journal of biomedical optics.

[13]  Kaiming Ye,et al.  Genetic engineering of an allosterically based glucose indicator protein for continuous glucose monitoring by fluorescence resonance energy transfer. , 2003, Analytical chemistry.

[14]  S. Daunert,et al.  Fluorescence Glucose Detection: Advances Toward the Ideal In Vivo Biosensor , 2004, Journal of Fluorescence.

[15]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[16]  Neil J Grey,et al.  Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[17]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[18]  J. Schultz,et al.  A fluorescence affinity hollow fiber sensor for continuous transdermal glucose monitoring. , 2000, Analytical chemistry.

[19]  J. DeVries,et al.  The use of two continuous glucose sensors during and after surgery. , 2005, Diabetes technology & therapeutics.

[20]  P. Szumita,et al.  Barriers to Glucose Control in the Intensive Care Unit , 2006, Pharmacotherapy.

[21]  Anthony Delaney,et al.  Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Metaanalysis , 2009 .

[22]  M. Madou,et al.  Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics , 2005, Nature Materials.

[23]  Homme W. Hellinga,et al.  Engineering Biosensors by Introducing Fluorescent Allosteric Signal Transducers: Construction of a Novel Glucose Sensor , 1998 .

[24]  T. Vo‐Dinh,et al.  Biosensors and biochips: advances in biological and medical diagnostics , 2000, Fresenius' journal of analytical chemistry.

[25]  Jean-Louis Marty,et al.  A review of the use of genetically engineered enzymes in electrochemical biosensors. , 2009, Seminars in cell & developmental biology.

[26]  B. Wang,et al.  Boronic Acid-Based Fluorescence Sensors for Glucose Monitoring , 2006 .

[27]  Lutz Heinemann,et al.  Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors , 2008, Diabetes Care.

[28]  Ashok Gowda,et al.  In vivo performance evaluation of a transdermal near- infrared fluorescence resonance energy transfer affinity sensor for continuous glucose monitoring. , 2006, Diabetes technology & therapeutics.

[29]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[30]  R. A. Ware,et al.  A novel reagentless sensing system for measuring glucose based on the galactose/glucose-binding protein. , 2001, Analytical biochemistry.

[31]  G. Mcgarraugh The chemistry of commercial continuous glucose monitors. , 2009, Diabetes technology & therapeutics.

[32]  Viviana Scognamiglio,et al.  D-galactose/D-glucose-binding Protein from Escherichia coli as Probe for a Non-consuming Glucose Implantable Fluorescence Biosensor , 2007, Sensors.

[33]  Joseph Wang,et al.  Glucose Biosensors : 40 Years of Advances and Challenges , 2001 .

[34]  J. Krinsley,et al.  Severe hypoglycemia in critically ill: Risk and outcomes , 2008 .

[35]  N. Evans,et al.  Fluorescence-based glucose sensors. , 2005, Biosensors & bioelectronics.

[36]  David L. Meadows,et al.  Design, manufacture and characterization of an optical fiber glucose affinity sensor based on an homogeneous fluorescence energy transfer assay system , 1993 .

[37]  N. Peppas,et al.  Physicochemical foundations and structural design of hydrogels in medicine and biology. , 2000, Annual review of biomedical engineering.

[38]  David C Klonoff,et al.  A review of continuous glucose monitoring technology. , 2005, Diabetes technology & therapeutics.

[39]  Lisa Halvorsen,et al.  Differences in glucose values obtained from point-of-care glucose meters and laboratory analysis in critically ill patients. , 2009, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[40]  H. Hellinga,et al.  Binding and signaling of surface‐immobilized reagentless fluorescent biosensors derived from periplasmic binding proteins , 2006, Protein science : a publication of the Protein Society.

[41]  H Szmacinski,et al.  Lifetime-based sensing of glucose using energy transfer with a long lifetime donor. , 1997, Analytical biochemistry.